OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
4.000
-0.240 (-5.66%)
Sep 9, 2026, 3:39 PM EDT - Market open
OmniAb Market Cap
OmniAb has a market cap or net worth of $581.56 million as of September 9, 2026. Its market cap has increased by 198.09% in one year.
Market Cap
581.56M
Enterprise Value
548.48M
1-Year Change
198.09%
Ranking
Category
Stock Price
$4.00
ChartMarket Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $581.56M, a decrease of -41.43%. That is a compound annual growth rate of -12.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 581.56M | 118.37% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 665.25M |
| Prime Medicine | 658.25M |
| CorMedix | 657.07M |
| Bright Minds Biosciences | 656.57M |
| Valneva SE | 637.30M |
| Contineum Therapeutics | 628.27M |
| Arvinas | 613.98M |
| ProKidney | 607.67M |